Director, Patient Marketing — Duchenne (Hybrid, MA)

ITF Therapeutics LLC; Concord (MA); Hybrid; USD 220,000 - 240,000; Full time

Job summary

ITF Therapeutics LLC in Concord, MA is seeking a Director of Patient Marketing for Duvyzat to lead the patient marketing strategy, engage patients, caregivers and families, and drive adoption while ensuring regulatory compliance.

This hybrid role requires 7+ years in marketing (rare disease preferred), 5+ years marketing to patient populations, demonstrated leadership, and experience with omnichannel campaigns and partner management. Base compensation ranges from $220,000 to $240,000.

Qualifications

• 7+ years of marketing experience, with rare disease or neurological disorders preferred.
• 5+ years marketing directly to patient populations.
• Experience leading a team of 1–3 marketers.
• Strong knowledge of FDA regulations for pharmaceutical marketing.

Responsibilities

• Lead patient marketing team to develop and execute Duvyzat patient marketing strategy.
• Oversee omnichannel campaigns across branded and non-branded channels.
• Mentor 1–2 marketers and drive capability development.
• Coordinate with Patient Advocacy, Thought Leader Engagement, and HCP Marketing teams to generate insights.
• Navigate FDA MLR requirements pertaining to patient marketing.
• Lead consumer product public relations and ambassador programs.

Skills

Marketing leadership

Rare disease marketing

Omnichannel marketing

Patient engagement

Team management

Regulatory/MLR knowledge

Analytics & KPI/ROI

Job description

ITF Therapeutics LLC in Concord, MA is seeking a Director of Patient Marketing for Duvyzat to lead the patient marketing strategy, engage patients, caregivers and families, and drive adoption while ensuring regulatory compliance.

This hybrid role requires 7+ years in marketing (rare disease preferred), 5+ years marketing to patient populations, demonstrated leadership, and experience with omnichannel campaigns and partner management. Base compensation ranges from $220,000 to $240,000.